-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Dthe I ( about 1,600 people ), the project is a 26-week, randomized, open the test, in T2D M announced Novo Nordisk after IDegLira of three research clinical research (Dual II) data, the study show, compared with Germany Valley insulin, compared with Germany Valley insulin, compared with Germany Valley insulin, IDegLira showed good efficacy and safety
Table 1 Comparison of main observation indexes between IDegLira group and insulin deglu
Table 2 Comparison of the proportion of glycated hemoglobin <7.
Table 2 Comparison of the proportion of glycated hemoglobin <7.
Therefore, IDegLira may be an effective and well-tolerated intensive treatment plan for Chinese T2DM patients whose basal insulin and oral hypoglycemic drugs are not effective
Pei Y, Agner BR, Luo B, et al.
Leave a message here